| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3419946 | Revue de Pneumologie Clinique | 2010 | 5 Pages |
Abstract
This experience indicates the feasibility of administering SLC in patients with MPM who are healthy at the time of the progression of the disease. The optimal treatment has not been defined to date and prospective trials are needed.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Infectious Diseases
Authors
J. Margery, F. Rivière, D. Planchard, H. Le Floch, F.-R. Ferrand, A. Mairovitz, B. Besse, F. Vaylet, P. Ruffié,